TuHURA Biosciences Inc. (HURA)
TuHURA Biosciences Statistics
Share Statistics
TuHURA Biosciences has 43.68M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 43.68M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 4,386 |
| FTD / Avg. Volume | 2.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -3.52 and the forward PE ratio is -4.84. TuHURA Biosciences's PEG ratio is -0.05.
| PE Ratio | -3.52 |
| Forward PE | -4.84 |
| PS Ratio | 0 |
| Forward PS | 1.7 |
| PB Ratio | 5.23 |
| P/FCF Ratio | -5.16 |
| PEG Ratio | -0.05 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for TuHURA Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.68, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.68 |
| Quick Ratio | 3.64 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | -4.26 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,141,174 |
| Employee Count | 19 |
| Asset Turnover | 0 |
| Inventory Turnover | 0.54 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -28.78% in the last 52 weeks. The beta is 0.79, so TuHURA Biosciences's price volatility has been higher than the market average.
| Beta | 0.79 |
| 52-Week Price Change | -28.78% |
| 50-Day Moving Average | 3.27 |
| 200-Day Moving Average | 5.14 |
| Relative Strength Index (RSI) | 52.45 |
| Average Volume (20 Days) | 217,734 |
Income Statement
| Revenue | n/a |
| Gross Profit | -116.71K |
| Operating Income | -17.65M |
| Net Income | -21.68M |
| EBITDA | -17.43M |
| EBIT | -17.54M |
| Earnings Per Share (EPS) | -1.21 |
Balance Sheet
The company has 12.66M in cash and 202.54K in debt, giving a net cash position of 12.45M.
| Cash & Cash Equivalents | 12.66M |
| Total Debt | 202.54K |
| Net Cash | 12.45M |
| Retained Earnings | -111.12M |
| Total Assets | 4.14M |
| Working Capital | 1.23M |
Cash Flow
In the last 12 months, operating cash flow was -14.73M and capital expenditures -57.91K, giving a free cash flow of -14.79M.
| Operating Cash Flow | -14.73M |
| Capital Expenditures | -57.91K |
| Free Cash Flow | -14.79M |
| FCF Per Share | -0.79 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HURA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for HURA is $11.5, which is 194.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.5 |
| Price Target Difference | 194.1% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Oct 18, 2024. It was a backward split with a ratio of 1:35.
| Last Split Date | Oct 18, 2024 |
| Split Type | backward |
| Split Ratio | 1:35 |
Scores
| Altman Z-Score | -16.73 |
| Piotroski F-Score | 2 |